Back
LENZ Therapeutics, Inc. 10K Form
Sell
24
LENZ
LENZ Therapeutics, Inc.
Last Price:
$27.85
Seasonality Move:
-9.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LENZ News And Ratings
See the #1 stock for the next 7 days that we like better than LENZ
LENZ Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.78 |
| Price / Book: | 4.5 |
Profitability
| EPS (TTM): | -2.10750 |
|---|---|
| Net Income (TTM): | $-58.9M |
| Gross Margin: | $-58K |
| Return on Equity: | -29.1% |
| Return on Assets: | -27.55% |
LENZ Therapeutics, Inc. Earnings Forecast
Key LENZ Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 1 years.
LENZ Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LENZ |
| Website: | lenz-tx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.69 |
| Quick Ratio: | 12.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LENZ Technical Analysis vs Fundamental Analysis
Sell
24
LENZ Therapeutics, Inc. (LENZ)
is a Sell
Is LENZ Therapeutics, Inc. a Buy or a Sell?
-
LENZ Therapeutics, Inc. stock is rated a SellThe current LENZ Therapeutics, Inc. [LENZ] share price is $27.90. The Score for LENZ is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.